Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Inhibitors of Α-Synuclein Fibrillation and Oligomer Toxicity in Rosa Damascena: The All-Pervading Powers of Flavonoids and Phenolic Glycosides Publisher Pubmed



Otzen DE1 ; Mohammadbeigi H1 ; Ward JL2 ; Eskandari H1 ; Ghanadian M3 ; Noletodias C1 ; Lomax C1 ; Tawfike A1 ; Christiansen G4 ; Sutherland DS1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Interdisciplinary Nanoscience Centre (INANO), Aarhus University, Aarhus, DK- 8000, Denmark
  2. 2. Computational and Analytical Sciences Department, Rothamsted Research, Harpenden, Herts, AL5 2JQ, United Kingdom
  3. 3. Department of Pharmacognosy, Isfahan Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Biomedicine-Medical Microbiology and Immunology, Aarhus University, Aarhus, 8000, Denmark

Source: ACS Chemical Neuroscience Published:2020


Abstract

There is an intense search for natural compounds that can inhibit the oligomerization and fibrillation of α-synuclein (α- Syn), whose aggregation is key to the development of Parkinson's disease (PD). Rosa damascena is a medicinal herb widely used in Middle Eastern food, ceremonies, and perfumes. The herb is known to contain many different polyphenols. Here we investigated the existence of α-Syn fibrillation inhibitors in R. damascena extract. Different HPLC fractions of the extract were assessed in α-Syn fibrillation and toxicity assays. The most active fractions led to the formation of more α-Syn oligomers but with less toxicity to SH-SY5Y cells, according to MTT and LDH assays. LC-MS analysis identified gallic acid, kaempferol 3-glucoside, kaempferol-3-O-β-rutinoside, and quercetin which were subsequently shown to be strong α-Syn fibrillation inhibitors. Our results highlight the benefits of R. damascena extract to combat PD at the population level. © 2020 American Chemical Society.
2. Neuroprotective Effects of Flavonoids, Phytonutrients and Neurological Disorders: Therapeutic and Toxicological Aspects (2023)
Experts (# of related papers)